|
|
|
Volumn 9, Issue 5, 2011, Pages 391-394
|
|
Updates in the management of medullary thyroid cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHYROID AGENT;
CARCINOEMBRYONIC ANTIGEN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
FLUOROURACIL;
LENVATINIB;
PLACEBO;
RADIOACTIVE IODINE;
SORAFENIB;
STREPTOZOCIN;
SUNITINIB;
VANDETANIB;
VASCULOTROPIN;
VINCRISTINE;
XL 184;
ABDOMINAL PAIN;
ARTICLE;
CANCER STAGING;
CARDIOTOXICITY;
CLINICAL TRIAL (TOPIC);
DECREASED APPETITE;
DERMATITIS;
DERMATITIS ACNEIFORM;
DIARRHEA;
DIFFERENTIATED THYROID CANCER;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG ERUPTION;
DRUG INDUCED HEADACHE;
DRUG RESPONSE;
DRUG TARGETING;
FAMILIAL CANCER;
FATIGUE;
GENE MUTATION;
GENETIC ASSOCIATION;
HUMAN;
HYPERTENSION;
LYMPH NODE METASTASIS;
MUTATIONAL ANALYSIS;
NAUSEA;
NEPHROTOXICITY;
NEUROFIBROMATOSIS;
ONCOGENE RET;
OVERALL SURVIVAL;
PATIENT MONITORING;
PHOTOSENSITIVITY;
PROGNOSIS;
SIPPLE SYNDROME;
SURVIVAL TIME;
THYROID MEDULLARY CARCINOMA;
THYROIDECTOMY;
TUMOR DIFFERENTIATION;
HUMANS;
MULTIPLE ENDOCRINE NEOPLASIA;
MUTATION;
PIPERIDINES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-RET;
QUINAZOLINES;
RESEARCH;
SYNDROME;
THYROID NEOPLASMS;
|
|
EID: 79959742655
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (6)
|
